Sensex rises 224 points to 32,424


Mumbai, 29 May 2020, Friday

The fourth phase of the lockdown is coming to an end as the Indian government prepares for the fourth phase of the lockdown after the global stock market softened today amid rising global tensions over the Hong Kong case and signs of tough action by the US against China. At the last minute, the funds took a hat-trick of gains over the weekend rather than a big rally in stocks.

The benchmark Sensex fell by 3.4 points to close at 314.30 after opening at 2031.5 against the previous close of 200.5 on early selling of funds in IT-software services stocks. After remaining in the negative zone for most of the day, funds have been aggressive in last-minute gains in oil-gas stocks led by ONGC and FMCG stocks in ITC, Nestle India, Hindustan Unilever and pharma stocks including Sun Pharma.

With this, auto stocks including Maruti Suzuki, Bajaj Auto, Hero MotoCorp and banking-finance stocks digested the decline from the previous high of 20.5 and closed at 8.10, up 3.31 points. While the Nifty spot opened at 8.30 against the previous close of 70.10 and came down to 5.30, then bounced back from the low and reached the top at 4.5 in the last hour, ending at 20.30, up 20.50 points.

The US dollar had lost 18 paise to close at Rs 4.5 against the rupee today. International crude oil prices were down 9 cents at ૩૪ 2.3 a barrel and Nymex crude was down 20 cents at ૮ 2.31 a barrel today. The BSE Oil-Gas Index rose by 31.6 points to close at 114.5 today on heavy buying by funds in oil and gas stocks. IOC up Rs 2.50 to Rs 2.50, Petronet LNG up Rs 19.50 to Rs 3.05, ONGC up Rs 4.5 to Rs 2.50, BPCL up Rs 15.5 to Rs 5 .50, HPCL rose by Rs. 5 to Rs. 18, Gail India rose by Rs. The BSE Healthcare Index rose by 2.15 points to close at 19.20 today on the back of widening of funds in healthcare-pharmaceuticals stocks.

Solara rose by Rs 4.5 to Rs 318.50, JB Chemicals by Rs 2.50 to Rs 31.5, Metropolis by Rs 4.5 to Rs 121.05, Diviz Lab by Rs 113.50. 4.5, AstraZeneca Pharma up Rs.151.9 to Rs.503.50, Aurobindo Pharma up Rs.21.50 to Rs.0.05, Dr. Reddy's Laboratories up Rs.12.50 to Rs.302.5, Sun Pharma Despite the poor results, the company announced a clinical trial for the pancreatitis drug, with shares rising by Rs 19.50 to Rs 4.5, Glenmark by Rs 11.5 to Rs 2.50 and Cipla by Rs 19.50 to Rs 4.50. , Biocon was up by Rs 3.15 to Rs 2.50.

FIIs, FPIs and foreign portfolio investors had net sales of Rs 5 crore in index futures and Rs 12 crore in stock futures today-Friday. In the cash segment, FPIs made a net purchase of Rs 160.71 crore today. Of this, a total of Rs 4,6.51 crore was sold against a total purchase of Rs 2,6.5 crore.

While DIIs-local institutional investors made a net purchase of Rs 4.5 crore in cash. Of this, a total of Rs 216.04 crore was sold against a total purchase of Rs 216.5 crore.

The BSE FMCG Index rose by 206.5 points to close at 104.5 on the back of a rebound in FMCG stocks. ITC up Rs 2.50 to Rs 12.5, Marico Industries up Rs 12.5 to Rs 3.10, Godrej Consumer up Rs 20.50 to Rs 2.50, Hindustan Unilever up Rs 2.5 .803.50, Britannia Industries rose by Rs. 20.15 to Rs. 3.30.

The BSE Auto Index also rose by 2.4 points to close at 1,307.8 on continued buying by funds in automobile stocks. Cummins India rose by Rs 19.50 to Rs 2.50, Bajaj Auto by Rs 115.15 to Rs 316.05, Motherson Sumi by Rs 2.15 to Rs 2.50, Hero MotoCorp by Rs 20.5 Rs 2.50, Maruti Suzuki rose by Rs 151.5 to Rs 318, Eicher Motors by Rs 4.5 to Rs 12.5, MRF by Rs 21.5 to Rs 2,05.

The stocks were positive today, especially in small, mid-cap stocks, re-funds, high net worth investors and a wide range of market breadths. Out of a total of 211 scrips traded on the BSE, the number of gainers was 1,318 and the number of losers was 21. The only seller in 12 stocks was the lower circuit against the upper circuit of the only buyer in 5 stocks.

Comments

Popular posts from this blog

Due to the ban, employment and economic activity declined by two to three percent

Information about soymilk and casein products

The brokerage firm objected to SEBI's new proposal regarding Algo Trading